Hyundai Pharmaceutical Co., Ltd. (004310.KS)
KRW 3710.0
(-2.62%)
KRW 3710.0
(-2.62%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 180.76 Billion | 162.69 Billion | 139.8 Billion | 132.96 Billion | 134.64 Billion | 130.79 Billion |
| Cost of Revenue | 105.52 Billion | 93.85 Billion | 83.48 Billion | 74.64 Billion | 70.96 Billion | 70.32 Billion |
| Gross Profit | 75.23 Billion | 68.83 Billion | 56.31 Billion | 58.32 Billion | 63.68 Billion | 60.46 Billion |
| Operating Expenses | 68.31 Billion | 60.86 Billion | 57.88 Billion | 55.26 Billion | 61.64 Billion | 63.12 Billion |
| Selling, General and Administrative Expenses | 31.06 Billion | 28.17 Billion | 22.93 Billion | 20.25 Billion | 23.73 Billion | 23.86 Billion |
| Research and Development Expenses | 12.23 Billion | 8.37 Billion | 8.08 Billion | 9.62 Billion | 11.8 Billion | 13.58 Billion |
| Other Expenses | 25.01 Billion | 24.31 Billion | 26.85 Billion | 25.38 Billion | 26.09 Billion | 26.14 Million |
| Cost and Expenses | 173.83 Billion | 154.71 Billion | 141.37 Billion | 129.91 Billion | 132.6 Billion | 133.44 Billion |
| Operating Income | 6.92 Billion | 7.97 Billion | -811.82 Million | 3.05 Billion | 3.46 Billion | -2.65 Billion |
| Interest Expense | 1.9 Billion | 1.16 Billion | 712.76 Million | 614.07 Million | 678.28 Million | 727.19 Million |
| Income Tax Expense | 1.91 Billion | 5.83 Billion | -847.54 Million | 495.8 Million | 310.19 Million | -1.02 Billion |
| Earnings before Tax | 8 Billion | 5.66 Billion | -4.02 Billion | 2.68 Billion | 1.52 Billion | -3.13 Billion |
| Net Income | 6.12 Billion | -164.58 Million | -3.17 Billion | 2.18 Billion | 1.21 Billion | -2.1 Billion |
| Earnings Per Share Basic | 225.81 | -5.92 | -113.82 | 79.91 | 44.49 | -76.00 |
| Earnings Per Share Diluted | 225.81 | -5.92 | -113.82 | 79.91 | 44.49 | -76.00 |
| Weighted Average Shares Outstanding | 27.1 Million | 27.81 Million | 27.87 Million | 27.36 Million | 27.26 Million | 27.71 Million |
| Weighted Average Shares Outstanding (Diluted) | 27.1 Million | 27.81 Million | 27.87 Million | 27.36 Million | 27.26 Million | 27.71 Million |
| Gross Margin | 0.42 | 0.42 | 0.40 | 0.44 | 0.47 | 0.46 |
| EBIT Margin | 0.07 | 0.06 | 0.02 | 0.06 | 0.05 | 0.01 |
| Profit Margin | 0.03 | -0.00 | -0.02 | 0.02 | 0.01 | -0.02 |
| EBITDA | 13.2 Billion | 10.04 Billion | 273.16 Million | 7.33 Billion | 5.58 Billion | 726.44 Million |
| Earnings Before Tax Margin | 0.04 | 0.05 | -0.01 | 0.02 | 0.03 | -0.02 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 46.22 Billion | 43.88 Billion | 42.77 Billion | 180.76 Billion | 45.56 Billion | 47.44 Billion |
| Cost of Revenue | 26.76 Billion | 25.32 Billion | 25.02 Billion | 104.16 Billion | 27.62 Billion | 28.45 Billion |
| Gross Profit | 19.45 Billion | 18.55 Billion | 17.75 Billion | 76.59 Billion | 17.94 Billion | 18.99 Billion |
| Operating Expenses | 19.86 Billion | 17.12 Billion | 16.58 Billion | 173.01 Billion | 45.98 Billion | 16.75 Billion |
| Selling, General and Administrative Expenses | 7.42 Billion | 13.97 Billion | 13.97 Billion | - | 8.17 Billion | 7.65 Billion |
| Research and Development Expenses | 5.88 Billion | 2.69 Billion | 2.52 Billion | - | 4.05 Billion | 3.08 Billion |
| Other Expenses | 6.55 Billion | -451.78 Million | -84.32 Million | -173.01 Billion | -45.98 Billion | 386.12 Million |
| Cost and Expenses | 46.62 Billion | 42.45 Billion | 41.6 Billion | 173.01 Billion | 45.98 Billion | 45.21 Billion |
| Operating Income | -407.74 Million | 1.42 Billion | 1.16 Billion | 7.74 Billion | -411.98 Million | 2.23 Billion |
| Interest Expense | 487.32 Million | - | 486.73 Million | 1.9 Billion | 514.5 Million | 473.76 Million |
| Income Tax Expense | -104.85 Million | 119.11 Million | 206.75 Million | 2.22 Billion | 424.53 Million | 515.75 Million |
| Earnings before Tax | -592.29 Million | 1.14 Billion | 612.69 Million | 8.84 Billion | 493.42 Million | 2.26 Billion |
| Net Income | -487.44 Million | 1.08 Billion | 309.18 Million | 6.12 Billion | 68.88 Million | 1.74 Billion |
| Earnings Per Share Basic | -19.00 | 41.25 | 11.64 | - | 2.58 | 64.94 |
| Earnings Per Share Diluted | -19.00 | 41.25 | 11.64 | - | 2.58 | 64.94 |
| Weighted Average Shares Outstanding | 25.65 Million | 26.22 Million | 26.56 Million | 27.1 Million | 26.67 Million | 26.92 Million |
| Weighted Average Shares Outstanding (Diluted) | 25.65 Million | 26.22 Million | 26.56 Million | 27.1 Million | 26.67 Million | 26.92 Million |
| Gross Margin | 0.42 | 0.42 | 0.42 | 0.42 | 0.39 | 0.40 |
| EBIT Margin | 0.01 | 0.05 | 0.05 | - | 0.00 | 0.06 |
| Profit Margin | -0.01 | 0.02 | 0.01 | 0.03 | 0.00 | 0.04 |
| EBITDA | 568.53 Million | 2.29 Billion | 2.02 Billion | - | 61.23 Million | 3.03 Billion |
| Earnings Before Tax Margin | -0.01 | 0.03 | 0.03 | 0.04 | -0.01 | 0.05 |
DGX
RYAOF
DHATRE
SXOOF
CSRA
NTGR